| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gene by Hepatitis B Virus preS1
The First Department of Internal Medicine [M. O., T. S., S. O.] and Laboratory of Molecular Biology, Medical Research Center [K. M., J. N., K. O., T. T.], Kochi Medical School, Okoh, Nankoku Kochi 783-8505, Japan
Hepatitis B virus (HBV) causes acute and chronic liver injury, and integration of HBV DNA is considered to be an important pathogenic determinant for hepatocarcinogenesis and tumor development. Transforming growth factor
(TGF-
) drastically accelerates hepatocarcinogenesis when it is overexpressed in TGF-
transgenic mice (C. Jhappan et al., Cell, 61: 11371146, 1990). In HBV-infected patients, hepatocellular carcinoma (HCC) cells show elevated expression of TGF-
(C. C. Hsia et al., J. Med. Virol., 43: 216221, 1994), the mechanism for which, however, has not been clarified yet. We here show that preS1, a part of the HBV large surface protein, carries a transcriptional transactivation domain and activates the transcription of the TGF-
gene by 2-fold in human HCC HuH6 cells. The responsive elements are restricted to the 315-bp segment of the proximal TGF-
promoter (-373 to -59). Furthermore, the expression of TGF-
was markedly increased in permanently preS1-producing HuH6 transformants. The crucial role for HBV preS1 in hepatocarcinogenesis and tumor development through transactivation of the TGF-
gene may give us new insight into the understanding of pathogenesis and therapy of viral hepatocarcinogenesis.
1 To whom requests for reprints should be addressed, at The First Department of Medicine, Kochi Medical School, Okoh, Nankoku, Kochi 783-8505, Japan. Phone and Fax: 81(888)80-2338; E-Mail: onishis@med.kochi-ms.ac.jp.
Received 12/22/97. Accepted 3/19/98.
This article has been cited by other articles:
![]() |
T. T.-T. Huy, H. Ushijima, K. M. Win, P. Luengrojanakul, P. K. Shrestha, Z.-H. Zhong, A. V. Smirnov, T. C. Taltavull, T. Sata, and K. Abe High Prevalence of Hepatitis B Virus Pre-S Mutant in Countries Where It Is Endemic and Its Relationship with Genotype and Chronicity J. Clin. Microbiol., December 1, 2003; 41(12): 5449 - 5455. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |